The Camp Lejeune lawsuit has entered a critical phase heading into 2026, with over 3,600 federal lawsuits filed and more than 409,000 administrative claims pending before the Department of the Navy. The filing deadline under the Camp Lejeune Justice Act passed on August 10, 2024, meaning no new claims are being accepted. To date, the government has paid out over $20 million in settlements, with individual payouts averaging around $246,000. The Elective Option settlement program has offered amounts ranging from $100,000 to $450,000 depending on the victim’s illness and duration of exposure, though uptake has been slow””only about 58 settlement offers have been accepted so far.
For example, a veteran with bladder cancer who spent more than five years at the base could receive the maximum Elective Option payment of $450,000, while someone with kidney disease and shorter exposure might receive $150,000. The litigation is now focused on preparing for Track 1 bellwether trials, which are expected to begin in 2026. These initial trials will address five disease categories: bladder cancer, kidney cancer, Parkinson’s disease, non-Hodgkin’s lymphoma, and leukemia. Twenty-five cases have been selected for this first round of trials, with plaintiffs’ attorneys pushing for kidney cancer cases to go first given that over 23,000 claimants suffer from this condition. This article covers the current status of claims processing, settlement amounts by disease tier, eligibility requirements, trial timelines, and what claimants can expect moving forward.
Table of Contents
- Why Are So Many Camp Lejeune Claims Still Pending?
- How Much Are Camp Lejeune Settlement Amounts by Disease?
- What Caused the Camp Lejeune Water Contamination?
- Who Is Eligible to File a Camp Lejeune Claim?
- When Will Camp Lejeune Bellwether Trials Begin?
- What Is the Elective Option and Is It Worth Accepting?
- What Is the Expected Total Payout for Camp Lejeune Victims?
- What Happens Next for Camp Lejeune Claimants?
- Conclusion
Why Are So Many Camp Lejeune Claims Still Pending?
The massive backlog of Camp Lejeune claims stems from the sheer volume of administrative filings combined with systemic processing challenges. As of early 2025, nearly 480,000 administrative claims had been filed with the Navy before the deadline passed, while just over 2,000 federal lawsuits were pending in court. By late 2025, the lawsuit count had grown to more than 3,600, but the administrative claims””now exceeding 409,000″”remain largely unresolved. The Navy has struggled to organize and process these claims efficiently. While a Claims Management Portal was established to streamline intake and processing, critics say the system has failed to adequately organize cases for review.
Only about 64,000 claims fall within the scope of the Elective Option settlement program, and fewer than half of those are being reviewed in a meaningful way. Starting in January 2025, the Navy began automatically submitting claims for review, which was intended to accelerate the process, but the impact has been limited given the overall volume. Comparatively, other mass tort litigations such as the 3M earplugs settlement or the talcum powder cases involved hundreds of thousands of claimants but had more established infrastructure from the outset. The Camp Lejeune litigation is unique because it involves claims against the federal government under a new statute, requiring the Navy to build its claims review process essentially from scratch. This has created frustration for claimants, many of whom are elderly or in declining health, waiting years for resolution.
How Much Are Camp Lejeune Settlement Amounts by Disease?
The Department of Justice has established a two-tier settlement structure under the Elective Option program, with payouts determined primarily by the claimant’s diagnosed illness and the duration of their exposure to contaminated water. Tier 1 conditions””which include bladder cancer, kidney cancer, liver cancer, non-Hodgkin’s lymphoma, and leukemia””qualify for higher settlement amounts. Tier 2 conditions include kidney disease (end-stage renal disease), multiple myeloma, Parkinson’s disease, systemic scleroderma, and systemic sclerosis, with payouts typically $50,000 less than Tier 1 amounts within the same exposure timeframe. Exposure duration is divided into three categories: 30 to 364 days, one to five years, and more than five years. A claimant with bladder cancer (Tier 1) and more than five years of exposure could receive up to $450,000, while someone with Parkinson’s disease (Tier 2) and similar exposure might receive $400,000.
For shorter exposures of 30 to 364 days, Tier 1 conditions might yield $150,000 to $200,000. An additional $100,000 is available for wrongful death claims where a family member died from a Camp Lejeune-related illness. However, these Elective Option amounts have drawn criticism from plaintiffs’ attorneys, who argue they represent only a fraction of what cases might be worth at trial. Many legal experts believe that 90 percent of cases would receive significantly higher verdicts if litigated successfully. The tradeoff is clear: accept a certain but potentially lower settlement now, or wait years for trial with the possibility of a much larger recovery””or nothing at all if the case is lost. For claimants with immediate financial needs or those in poor health, the Elective Option may still be the right choice despite the lower amounts.
What Caused the Camp Lejeune Water Contamination?
Between 1953 and 1987, the drinking water at Marine Corps Base Camp Lejeune in Jacksonville, North Carolina, was contaminated with toxic industrial chemicals at concentrations ranging from 240 to 3,400 times what is now considered safe. Two water-supply systems on the base””the Tarawa Terrace and Hadnot Point water-treatment plants””served enlisted-family housing, barracks, administrative offices, schools, and recreational areas for decades while contaminated. The primary contaminants were trichloroethylene (TCE), tetrachloroethylene (PCE), vinyl chloride, and benzene. TCE and PCE are volatile organic compounds used as industrial solvents and in dry cleaning operations. Benzene is a chemical used in manufacturing plastics, synthetic fibers, and is also found naturally in gasoline.
The Tarawa Terrace system was primarily contaminated by PCE from an off-base dry cleaner called ABC One-Hour Cleaners, where spills and improper disposal allowed chemicals to seep into groundwater. The Hadnot Point system was contaminated by TCE from leaking underground storage tanks, waste disposal sites, and industrial spills on the base itself. For example, during February 1985, PCE concentrations in the Tarawa Terrace system reached 215 parts per billion””43 times above the EPA’s maximum safe level of 5 parts per billion. The Agency for Toxic Substances and Disease Registry (ATSDR) estimated that PCE concentrations exceeded safe limits for 346 months””nearly 29 years. Documents released in 2012 showed Marine officials knew some wells were contaminated as early as 1980, but the contaminated wells were not shut down until 1984-1985, and the Tarawa Terrace plant remained open until 1987. An estimated 950,000 people may have been exposed during this period.
Who Is Eligible to File a Camp Lejeune Claim?
Eligibility for Camp Lejeune claims extends to anyone who lived, worked, or was otherwise exposed to the contaminated water for at least 30 cumulative days between August 1, 1953, and December 31, 1987. This includes active-duty service members stationed at the base, their dependent family members who resided there, civilian employees, contract workers, and even children who were in utero during the exposure period. Surviving family members””including spouses, parents, children, or siblings””may file on behalf of deceased individuals who would have qualified. Claimants are not required to have served in the Marine Corps specifically. Members of the Army, Navy, Air Force, National Guard, and Reserves who spent time at Camp Lejeune during the contamination period may also be affected.
The key documentation requirements include military service records (typically the DD Form 214), comprehensive medical records showing diagnosis and treatment for a qualifying health condition, and for non-service members, proof of relationship such as marriage certificates, birth certificates, or guardianship papers. The critical limitation is that the filing deadline has passed. The Camp Lejeune Justice Act required all administrative claims to be filed by August 10, 2024″”two years after the law was signed. If you missed this deadline, you cannot file a new claim regardless of how strong your case might be. All claims must be filed in the Eastern District of North Carolina, which has exclusive jurisdiction, though claimants do not need to be North Carolina residents. Claimants who filed before the deadline and are represented by attorneys can check their claim status through the CLJA Claims Portal or by contacting their legal representative directly.
When Will Camp Lejeune Bellwether Trials Begin?
Track 1 bellwether trials are expected to begin in 2026, though exact dates have not been set. These initial trials will focus on five disease categories: bladder cancer, kidney cancer, Parkinson’s disease, non-Hodgkin’s lymphoma, and leukemia. Twenty-five cases have been selected for this first round, and both sides are negotiating trial format. Plaintiffs’ attorneys are pushing for kidney cancer cases to go first, given that over 23,000 claimants have this diagnosis. The timeline has been delayed by extensive legal maneuvering.
The government has filed more than 30 Daubert motions””challenges to the admissibility of expert testimony””in an attempt to exclude every plaintiff expert witness and dismiss all Track 1 bellwether cases. These motions are extraordinarily lengthy; the defendant’s Phase II/III briefs alone totaled 690 pages and more than 233,000 words. A November 2025 motion from plaintiffs’ counsel accused the government of “burying” the case under “a mountain of redundant, meritless motions.” The court must resolve these evidentiary disputes before trials can proceed. Mediation on the 25 bellwether cases occurred in summer 2025 but was largely unsuccessful””almost all cases remain scheduled for trial rather than settling. This signals that both sides believe they can prevail at trial, which may be good or bad news for claimants depending on the outcome. A plaintiff victory in early bellwether trials could dramatically accelerate settlement negotiations for the remaining 400,000-plus claims, while government victories could suppress settlement values or encourage the Navy to take a harder line in negotiations.
What Is the Elective Option and Is It Worth Accepting?
The CLJA Elective Option, announced in September 2023, provides a framework for resolving qualifying claims more quickly than through full litigation. Claimants with one of the presumptive conditions who resided or worked at Camp Lejeune for at least 30 days may be eligible. Settlement amounts range from $100,000 to $450,000 based on disease severity and exposure duration, with an additional $100,000 available for wrongful death claims. The Elective Option has been a disappointment for all parties. Of the roughly 480,000 administrative claims, only about 64,000 fall within the program’s scope, and fewer than half of those are under active review. As of late 2025, only 93 cases had received Elective Option offers, and just 37 of those offers had been accepted.
The average settlement has been around $246,000. Even the Department of Justice has expressed frustration that the program has not achieved its goal of significantly reducing the litigation backlog. For example, a veteran with bladder cancer who accepts a $450,000 Elective Option payment receives that amount with certainty, minus attorney fees and costs. The same veteran taking the case to trial might recover $1 million or more””but trial is years away, and the government could win, leaving the claimant with nothing. Claimants in poor health, those with significant financial pressures, or those with weaker medical documentation may find the Elective Option worthwhile despite its limitations. Those with strong cases and the ability to wait may be better served by holding out for trial or a more favorable global settlement.
What Is the Expected Total Payout for Camp Lejeune Victims?
The Congressional Budget Office has estimated that total spending under the Camp Lejeune Justice Act will eventually reach $21 billion over the coming decade. Individual settlements are projected to range from $10,000 for cases with limited exposure or less serious conditions to over $1 million for claimants with severe illnesses and extensive exposure documentation who prevail at trial or receive favorable settlement terms.
What Happens Next for Camp Lejeune Claimants?
Attorneys representing Camp Lejeune victims have expressed hope for a global settlement by the end of 2025 or early 2026, though this depends heavily on bellwether trial outcomes and continued negotiations. Two special masters””Thomas Perrelli of Jenner & Block and Christopher Oprison of DLA Piper (a former Marine Corps captain)””were appointed in July 2024 to facilitate settlements. Their involvement suggests the courts and both parties recognize the need to resolve these cases without trying hundreds of thousands of individual lawsuits.
Looking ahead, claimants should prepare for continued waiting but also for potential movement once bellwether trials conclude. Trial verdicts will establish case values and create pressure on both sides to negotiate. Claimants who have already filed should stay in contact with their attorneys, ensure their medical documentation is complete, and monitor developments through the CLJA Claims Portal or news coverage. Those who were considering filing but missed the deadline have no legal recourse under the Camp Lejeune Justice Act, though VA disability benefits remain available for veterans with qualifying conditions.
Conclusion
The Camp Lejeune lawsuit represents one of the largest mass tort actions against the federal government in American history, with over 409,000 administrative claims and 3,600 federal lawsuits pending. The litigation has moved past the filing deadline phase and is now focused on preparing for Track 1 bellwether trials expected in 2026. While the Elective Option settlement program has provided some early payouts ranging from $100,000 to $450,000, uptake has been limited, and most claimants are waiting for trial outcomes or a potential global settlement.
Claimants should maintain realistic expectations about timing while staying engaged with their legal representatives. The appointment of settlement masters and the progression toward bellwether trials suggest the courts are working toward resolution, but the government’s aggressive litigation tactics have slowed progress. For those who filed claims before the August 2024 deadline, the path forward involves patience, complete medical documentation, and close communication with counsel as the litigation continues to develop.